We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
dickie3times - you might also still have time to register for tonights webinar if you want - 6pm is no good for me sadly, but I'm sure the highlights will be on here.
Suggest you pop over to Bould's website to have a read of the prospectus for our pending admission to the main market.
I have stopped following BOU as i am wasting too much time. But now i am confused...no news yet posters are talking as if something is happening. So are we going to relist or not.. anyone know anything?
I have just signed up for the webinar, should be very interesting.
Morning,
another liquid biopsy company (Inivata), which at some point i thought it is our target, has been acquired by a big pharma, look at #ipo rns today. We have the advantage of listing with a low sp which will multibag in time, I would definitely keep cizzle and for few months.
Why?
Marko you are up and down like a bride's nightie.
I’ll send my congratulations card to the investor on the 14th for getting in at the same price as me with zero risk...
However, yes it sounds like a great opportunity I agree
I have a good feeling about our new company. I think they are ready to go. Few grounds ready for an admission day to average down :-) I know few will do the same. Next week 14th May will be crazy day!! Can't wait to see their presentation this week. In it to win it!
GL all
Antos would not accept a big dilution of his holding for nothing, I am beginning to sence there has been far more progress accomplished than we know. Let us hope the Q & A webinar will be very informative.
Aspen
"Shortly after the Acquisition, it is proposed that the group, as enlarged by the Acquisition (the “Enlarged Group”) will enter into agreements with selected manufacturers and contract research organisations to conduct the reagent generation, test manufacture and the clinical validation required to achieve CE marking and/or FDA510(K) clearance"
Sounds to me like they are pretty well advanced if they are looking at that.
Been reading up on some of the medical journals ( i really should get out more!) and it looks to me that this is bigger than first seems. We appear to be focusing on lung cancer, but as i said earlier, it also acts as a detector for breast, colon, prostate, gall cancers etc. reading some of the papers submitted, it appears that the CIZ1 protein has 22 variants (that is known at present) and has also been associated with gastric cancers, Alzheimers, rheumatoid athritis, and Ewings tumour.
One that stood out was the incidence of brain tumours. Apparently these are only detectable when they have become solid tumour, and there is no cure, with a very poor prognosis. They can't be detected earlier due to "blood brain barrier" If our test can overcome this barrier, and detect the protein before it becomes tumour, just imagine the medical need. The more i read into this research, the better this looks.
Neil
Yes mate,
I've been mulling over a few things people have gleaned from that prospectus and what you've just posted adds more weight to the thought.
At which stage is this product. And why 20 days a year?
1. "Previous commercial engagement":
https://www.finance-yorkshire.com/news/news139.asp
2. "Subsequent technological improvement":
The fact that what we have can identify 95% of the patients who actually have the disease shows how useful this is. There may better, but atleast we are not looking at 60%, 70% or 80% sensitivity.
Here's hoping with what more we find out, that the market believes CIZ is heavily undervalued at 10p.
Time will tell, I believe this might have some serious potential.
Gla
Hopefully after the Q & A session, we should be better informed.
Aspen
taken from the last update= ”..... it allows it to acquire technology which has benefitted from a previous commercial engagement and subsequently technological improvement, but before final commercial terms have been reached with a licencing partner......”
reading this paragraph, i am assuming they are already in discussion with a partner? but happy to be corrected.